Niagen Bioscience, Inc. — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2015-07-06

Reporting Person: Jaksch Frank L Jr (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-06	Employee Stock Options (right to buy)	$1.22	A	150000	Acquired	2025-07-06	Common Stock (150000)	Direct

Footnotes

F1: Options vest 25% on July 6, 2016 with the remainder vesting 1/36th per month over three years thereafter.

F2: The total includes 3,776,418 options under different terms.